Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Wright who wrote (61)	1/10/1997 6:13:00 AM
From: John Wright	of 1494

>>>> If the theory is correct, another drug being studied in PWAs for neurologic problems, nimodipine, may increase the effect of memantine. An excerpt from the PWA thread, the above is interesting from an NTII perspective. If memantine is effective in treating aids related dementia and nimodipine does increase its effectiveness wouldn't it seem like a natural for NTII to form some type of marketing deal with the manufacturer of nimodipine. Thoughts anyone? John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next